Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Portugal MenB vaccine effectiveness study
ISRCTN10901628Phase 4Completed
- Sponsor
- Sociedade Portuguesa de Pediatria
- Start
- Apr 2019
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, open-label trial of Multicomponent meningococcal B vaccine in meningococcal disease (2 arms), sponsored by Sociedade Portuguesa de Pediatria. Started Apr 2019; status: completed.
02
Drugs
Multicomponent meningococcal B vaccine
03
Conditions
meningococcal disease
Beyond the preview
Go deeper on ISRCTN10901628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN10901628.